Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Patent: 9,982,051

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,982,051
Title:Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
Abstract: A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (RRMS), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two courses of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.
Inventor(s): Eisenbach-Schwartz; Michal (Rehovot, IL), Baruch; Kuti (Rehovot, IL), Rosenzweig; Neta (Rehovot, IL)
Assignee: Yeda Research and Development Co. Ltd. (Rehovot, IL)
Application Number:15/821,678
Patent Claims:see list of patent claims

Details for Patent 9,982,051

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 2016-05-18 ⤷  Free Forever Trial 2034-03-12
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 2019-03-08 ⤷  Free Forever Trial 2034-03-12
Emd Serono, Inc. BAVENCIO avelumab Injection 761049 2017-03-23 ⤷  Free Forever Trial 2034-03-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.